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Abstract The p opioid receptor was shown to be phosphor- 
ylated at a basal rate in the absence of agonist, measured in 
permeablllzed HEK293 cells transfected with an epitope tagged 
p receptor (EE-p) [Arden, J., Segredo, V., Wang, Z., Lameh, J. 
and Sad&e, W. (1995) J. Neurochem. 65, 163616451. In the 
present study, basal phosphorylation was found to be Ca’+ 
dependent; however, several inhibitors of protein kinase C and 
Ca*+-cahnodulin dependent kinases failed to affect basal F 
receptor phosphorylation. Thus, the basal p receptor phosphor- 
ylating activity differed from the main kinases involved in 
receptor regulation. The general kinase inhibitor H7 (100 pM) 
suppressed basal p receptor phosphorylation. Pretreatment with 
the agonist morphine, followed by drug removal, resulted in a 
sustained increase of basal p receptor phosphorylation. The 
gradual agonist dependent modulation of basal p receptor 
phosphorylation suggests a novel regulatory mechanism which 
may play a role in narcotic tolerance and dependence. 
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1. Introduction 
The p opioid receptor was shown to be continuously phos- 
phorylated at a basal rate in the absence of agonist, using 
[y-32P]ATP labeling of permeabilized HEK293 cells trans- 
fected with an epitope tagged p opioid receptor (HEK-EE- 
p) [l]. A basal rate of CL receptor phosphorylation has been 
confirmed to occur in other cells with heterologous or native 
expression of the p receptor, including brain slices [2,3], sug- 
gesting that this phenomenon is not limited to HEK293 cells. 
Similarly high basal levels of receptor phosphorylation were 
previously observed with a constitutively active pz receptor 
mutant [4], and with the serotonin 5-HTzc wild-type receptor 
which displays basal signaling activity [5]. These results are 
consistent with the hypothesis that the p opioid receptor also 
has a basal (constitutive) signaling activity which might be 
modulated by concurrent phosphorylation [6]. Basal p recep- 
tor phosphorylation, i.e. the rate in the absence of any ago- 
nist, was further enhanced in the presence of morphine [l], as 
observed upon agonist stimulation of the constitutively active 
pz receptor mutant [4]. 
We have previously demonstrated that morphine pretreat- 
ment sensitized the p opioid receptor ‘inverse agonist’ effects 
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of naloxone in SH-SYSY neuroblastoma cells, as a possible 
element of the dependent state [6]. This sensitization to nalox- 
one was prevented by the general kinase inhibitor H7, but not 
its congener H8 [6]. To determine the possible involvement of 
a phosphorylation reaction in narcotic tolerance and depend- 
ence, we tested the general kinase inhibitors H7 and H8 in 
mice made acutely tolerant to and dependent on morphine 
[6,7]. Compound H7, but not its congener H8, reversed mor- 
phine tolerance and dependence [6,7], in parallel to in vitro 
results in SH-SYSY cells [6]. These findings supported the 
hypothesis that a phosphorylation event contributes to the 
expression of narcotic tolerance and dependence. 
This report characterizes basal ~1 receptor phosphorylation 
with regard to ionic requirements, spectrum of inhibitors, and 
response to the agonist morphine. Basal p receptor phosphor- 
ylation was found to be Ca ‘+ dependent, modulated by mor- 
phine pretreatment, and suppressed by H7. 
2. Materials and methods 
2.1. Materials 
N-Methyl-[3H]morphine (79 Ci/mmol) was purchased from NEN 
(Boston, MA), and [15,16-3Hz]diprenorphine (specific activity 47 Ci/ 
mmol) was provided by the National Institute on Drug Abuse, Rock- 
ville, MD. The following protein kinase inhibitors were used (source 
given in parentheses): H7, calmodulin dependent protein kinase II 
fragment 290-309 (CaM kinase inhibitor peptide) (Sigma Chemicals, 
St. Louis, MO), H8 (Seikagaku American Inc., Rockville, MD), H89, 
HA1004, staurosporin, W7, herbimycin A, heparin (Calbiochem, La 
Jolla, CA), PKC (19-31) inhibitor peptide, chelerythrine chloride, PKI 
(5-24) peptide (PKA inhibitor), K-525a, KN-62, and peptide A (tyr- 
osine k&se inhibitor) (LC Laboratories, Woburn, MA). 
The rat u onioid receotor cDNA in vector aRC/CMV 181. arovided 
by Dr. Lei Y;, Indiana University, was tagged with a He&ence en- 
coding the epitope EYMPME, immediately downstream of the Met 
initiation codon (EE-p) [I]. 
2.2. Cell culture 
The plasmid encoding the EE-p receptor was transfected into 
HEK293 cells, and stably transfected clonal cell lines were established 
as described [I]. The cell line with the highest receptor expression 
initially contained 5 x IO6 sites per cell for HEK-EE-p [I]. As a result 
of gradual loss of p receptor sites during culture, experiments were 
performed with cultures expressing 5-10 x IO5 sites per cell. 
2.3. Receptor binding and CAMP assays 
Receptor expression was examined with 2 nM [3H]diprenorphine in 
intact cell monolayers, and CAMP levels by radioimmunoassay as 
described [I]. 
2.4. Drug pretreatment protocol 
Cells were pretreated with 1 pM morphine and/or the indicated 
inhibitors for O-12 h. Immediately before the 32P-labeling incubation. 
cells were washed twice with medium containing 5% serum and twice 
more with serum-free medium, requiring IO min for effective agonist 
removal. Studies with [3H]morphine indicated that this procedure re- 
moved 99.7% of the 3H activity added to the preincubation. 
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2.5. Phosphorylation and immunoprecipitation of the epitope tagged 
b receptor 
Phosphorylation of EE-p was determined in washed, permeabilized 
cells as described [l]. Briefly, digitonin permeabilized cells were la- 
beled with 0.2 mCi [y-32P]ATP (200 FM, 0.5 ml) at 25°C for 15 min 
in the presence or absence of morphine or kinase inhibitors, The 
incubation medium consisted of either DMEM medium (containing 
Ca2+ and Na+ ions) [l], or the buffers indicated in the text. Optimal 
labeling conditions for basal u receptor phosphorylation were ob- 
served in a medium containing 150 mM NaCl, 5 nM CaCls, 10 
mM HEPES (pH 7.1) 2 mM MgCla, 5 mM glucose, and 200 uM 
[y-32P]ATP. Labeled cells were washed and homogenized in the pres- 
ence of 100 nM diprenorphine and protease inhibitors [I]. The 
30000 Xg membrane pellet was solubilized in 10 mM CHAPS, con- 
taining 100 nM diprenorphine. Solubilized EE-p was immunoprecipi- 
tated with anti-EE mAb, subjected to SDS-PAGE, autoradiographed, 
and analyzed by scanning densitometry, as described previously [l]. 
The identity of the labeled EE-u band was confirmed by Western 
blotting [l]. 
3. Results 
3.1. Ionic requirements for basal p receptor phosphorylation 
We have previously shown that the p receptor in HEK-EE- 
u cells is phosphorylated in the absence of any agonist [l]. 
32P-labeling of the EE-p receptor was obtained in DMEM 
medium which contains 2 mM Ca2+ and 150 mM Na+ [l]. 
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Fig. 1. Phosphorylation of the EEy receptor: ionic requirements. 
HEK-EE-u cells were permeabilized, labeled with [y-32P]ATP in the 
presence of 10 uM morphine, immunoprecipitated, and separated 
on SDS-PAGE, as described [l]. The 32P-labeling reaction was per- 
formed in 10 mM HEPES buffer, pH 7.1, 5 mM glucose, and the 
following ionic conditions: lane 1: 150 mM KCl, 7 mM MgCls, 
5 mM EGTA; lane 2: 150 mM KCI, 2 mM MgCla, 2 mM CaCla; 
lane 3: 150 mM NaCl, 7 mM MgCla, 5 mM EGTA; lane 4: 150 
mM NaCl, 2 mM CaCls, 2 mM MgCla. The requirement for Ca2+ 
was confirmed in three additional experiments with varying ionic 
compositions, both in the presence and in the absence of morphine. 
Even though the labeling intensity of the 65 kDa band in lane 2 
(Caz+) was lower than that in lane 4 (Ca2+ and Na+), the presence 
of Na+ did not enhance labeling in other experiments. 
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Fig. 2. Basal phosphorylation of the p receptor: inhibitors H7 and 
H8. Permeabilized HEK-EE-p cells were incubated for 15 min with 
a medium containing 150 mM Na+, 5 pM Ca’+, 200 pM 
[y-32P]ATP, and 100 pM H7 or H8. Lane 1: control cells; lane 2: 
H7; lane 3: H8. 
To determine the ionic requirements for this reaction, we in- 
cubated the permeabilized cells in medium containing 150 mM 
K+, 7 mM Mg2+, and 5 mM EGTA to chelate Ca2+, com- 
monly used conditions to study intracellular kinases, including 
the GRKs [4,9,10]. Under these conditions, no basal phos- 
phorylation was detectable at 65 kb (not shown), and only a 
moderate level of phosphorylation appeared at 65 kb during 
acute stimulation with 1 uM morphine (Fig. 1, lane 1). It 
remains to be determined whether the labeling at higher mo- 
lecular weights is related to the u opioid receptor, but Western 
blot analysis did not reveal immunoreactive bands at high 
molecular weights [l]. The morphine enhanced phosphoryla- 
tion activity at 65 kDa may be mediated by one of the known 
G protein coupled receptor kinases (GRKs). This putative 
agonist dependent GRK-like activity is being investigated in 
a separate study. 
Replacement of K+ with 150 mM Na+ (in the absence of 
Ca2+) generally reduced detectable phosphorylation, as ex- 
pected since Na+ inhibits many intracellular kinases, including 
the GRKs (Fig. 1, lane 3). In contrast, the addition of 2 mM 
Ca2+ stimulated u receptor phosphorylation, yielding a clear 
band at 65 kb, regardless of the presence or absence of Na+ 
(Fig. 1, lanes 2 and 4). Therefore, to measure u receptor 
phosphorylation, we included both Ca2+ and Na+ ions, the 
latter to suppress GRKs and extraneous kinase activities. To 
determine the Ca2+ concentration required for basal u recep- 
tor phosphorylation, the reaction was carried out at 5, 50, 
500, and 2000 uM Ca 2+ Maximal l.t receptor phosphorylation . 
Z. Wang et al.IFEBS Letters 387 (1996) 53-57 
was already attained at 5 nM Ca2+, the lowest Ca2+ concen- 
tration tested (data not shown). 
The results shown in Fig. 1 were obtained in the presence of 
10 uM morphine to enhance EE-n labeling [l]. In the absence 
of morphine, basal p receptor phosphorylation also depended 
upon Ca2+ and was not suppressed by high levels of Na+ 
(data not shown). Therefore, basal and morphine stimulated 
p receptor phosphorylation measured under these conditions 
appear to be mediated by the same or a similar kinase activity. 
3.2. Effect of kinase inhibitors on basal p receptor 
phosphorylation 
We first tested the general kinase inhibitors H7 and H8. 
Addition of 100 pM H7 to permeabilized HEK-EE-n cells 
strongly inhibited basal phosphorylation to undetectable le- 
vels (n = 3) (Fig. 2, lane 2). Compound H8 (100 nM) inhibited 
basal I_L receptor phosphorylation only partially in permeabi- 
lized HEK-EE-p cells (n = 2, Fig. 2, lane 3). 
To characterize the n receptor kinase activity, we tested 
inhibitors with selectivity for kinases commonly involved in 
receptor regulation, such as PKA and PKG, and the main 
classes of Ca2+ dependent kinases, including protein kinase 
C (PKC) and Ca2+ -calmodulin dependent (CaM) kinases 
[l 11. A representative experiment is shown in Fig. 3. The 
chosen concentrations of these kinase inhibitors were -2O- 
fold higher than published I& values for the respective ki- 
nases, except for W7 which was tested at 200 FM, or only 
N S-fold the ICsc for calmodulin, to avoid nonspecific effects 
(see legend, Fig. 3). None of these inhibitors strongly sup- 
pressed basal p receptor phosphorylation (Fig. 3). In a second 
experiment with W7, a reduction of basal n receptor phos- 
phorylation was detectable (N 60%) and therefore this experi- 
ment was repeated a third time with 200 and 500 pM W7. In 
the third experiment, a clear inhibition (>50%) was seen only 
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Fig. 3. Basal phosphorylation of the u receptor: effect of protein ki- 
nase inhibitors. HEK-EE-u cells were labeled as described for Fig. 
1. The following inhibitors were added to the labeling medium (the 
kinases expected to be strongly inhibited are given in parentheses): 
lane 1: control without any inhibitor; lane 2: 50 nM K252a 
(CaMK); lane 3: 200 uM W7 (CaMK, MLCK); lane 4: 20 uM 
chelerythrine (PKC); lane 5: 20 pM KN62 (CaMK); lane 6: 30 uM 
HA1004 (PKA, PKG); lane 7: 1 uM calmodulin dependent protein 
kinase II fragment 29&309 (CaMK); lane 8: 10 nM staurosporin 
(MLCK, PKC). These results were repeated in independent experi- 
ments for the following inhibitors: W7, chelerythrine, KN62, and 
CaM kinase II fragment (for additional inhibitors see text). 
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Fig. 4. Effects of morphine, H7, and H8 on u receptor phosphoryla- 
tion. HEK-EE-u cells were labeled as described for Fig. 1. A: Acute 
treatment of permeabilized cells. Receptor labeling was determined 
over 15 min in the presence of 10 uM morphine (lane l), no drug 
(lane 2), or 100 uM H7 (lane 3). B: Pretreatment of intact cells 
with morphine, H7 and H8, followed by removal of the drug. Pre- 
treatment of the intact cells was performed for 7 h with no drug 
(lane 4) 1 uM morphine (lane 5) -1 pM morphine plus 100 uM H8 
(lane 6). 1 uM moruhine nlus 100 uM H7 (lane 7). 100 uM H7 
(lane 8); and 100 uM H7 *with subsequent 32P-labeling in the pre- 
sence of 10 uM morphine (lane 9). Drugs in the pretreatment me- 
dium were removed by 4X washing before permeabilizing the cells. 
Thus, only the experiment shown in lane 9 contained morphine dur- 
ing 32P-labeling. Each condition in A and B was repeated at least 
twice, with similar results. 
with the 500 nM concentration. Therefore, W7 appeared to be 
a weak inhibitor of basal p receptor phosphorylation at best, 
but at concentrations that exceed its expected ICse concentra- 
tion for calmodulin inhibition (-40 FM). It should be noted 
that these experiments were designed for semiquantitative 
analysis suitable for detecting strong inhibition (>SO%) 
only, since each control (basal phosphorylation without any 
inhibitor) was run only once per experiment, and the absolute 
level of 32P-labeling varied from one experiment to another, 
probably owing to variable recovery of the receptor on the 
gel. 
To test a spectrum of potential inhibitors, we then initiated 
a screen of known inhibitors of various kinases, using single 
experiments. None of the following inhibitors affected n re- 
ceptor phosphorylation in single experiments: 5 pM H89 
(PKA inhibitor), 10 pM herbimycin A (tyrosine kinase inhib- 
itor), 1 pM heparin (GRK2 inhibitor), and selective peptide 
inhibitors of PKC (1 PM), PKA (0.2 pM), and tyrosine ki- 
nases (20 pM) (see section 2.1). 
3.3. Regulation of basal CL receptor phosphorylation by 
pretreatment with morphine, H7, and H8 
Fig. 4 compares the effects of acute addition and of pre- 
treatment on basal n receptor phosphorylation. Acute treat- 
ment of permeabilized cells with 1 pM morphine stimulated, 
whereas 100 nM H7 abolished, p receptor phosphorylation 
(Fig. 4A) (see also Fig. 2, lane 2 and ref. [l]). To determine 
the effect of chronic p receptor stimulation, we next deter- 
mined basal p receptor phosphorylation after morphine pre- 
treatment, followed by complete agonist removal. Pretreat- 
ment of intact cells with 1 nM morphine for 7 h 
significantly increased subsequent p receptor phosphorylation 
nearly 3-fold (Fig. 4B, lane 5, 2.6 f O.Cfold, n= 5) even 
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Fig. 5. Dose-response curve and time course of the effects of mor- 
phine pretreatment on l.t receptor phosphorylation. HEK-EE-u cells 
were labeled as described for Fig. 1. For the dose-response experi- 
ment, cells were preincubated for 12 h with 0, 10, 100, 1000 nM 
morphine (lanes 14, respectively), followed by washout and 32P-la- 
beling. For the time course (lanes 5-lo), cells were pretreated for 
0.5, 2, 6 hours (lanes 5-7), and allowed to recover after agonist re- 
moval for 0.5, 2, and 6 h (lanes 8-10). 
though the agonist was removed before labeling. A morphine 
dose-response experiment and a time course with 1 pM mor- 
phine pretreatment are shown in Fig. 5. Maximal stimulation 
after a 12 h pretreatment was attained with 100 nM morphine 
(Fig. 5, lane 3). Furthermore, a 2 h pretreatment with 1 l.tM 
morphine was required to reach maximum (Fig. 5, lanes S-7). 
After morphine removal, elevated basal u phosphorylation 
persisted for at least 2 h (Fig. 5, lanes 8-10). 
Preincubation of intact HEK-EEy cells with 100 pM H7 
alone for 7 h, followed by removal of the inhibitor, suppressed 
subsequent basal p receptor phosphorylation by >90% (n = 2) 
even though the inhibitor was no longer present (Fig. 4B, lane 
8). The same strong inhibition was seen with a 100 pM H7 
preincubation for 2 h. Basal phosphorylation of the p receptor 
was also suppressed when HEK-EE-p cells were preincubated 
with H7 (100 pM) together with morphine (1 pM) (Fig. 4B, 
lane 7, n = 3). The ability of the p receptor to undergo phos- 
phorylation was not abolished by H7 pretreatment, since after 
removal of the inhibitor, addition of morphine to the labeling 
incubation now caused a significant increase of receptor phos- 
phorylation (approximately 3-5-fold, R = 3) (Fig. 4B, lane 9). 
However, the absolute intensity of this morphine induced 
phosphorylation was considerably lower than that without 
H7 pretreatment. 
In contrast to the results with H7, pretreatment of intact 
HEK-EEy cells with 100 pM H8 alone (data not shown) or 
together with 1 pM morphine, followed by drug removal, 
failed to reduce subsequent basal p receptor phosphorylation 
(Fig. 4B, lane 6; llOf20% (n= 3) relative to the level with 
morphine pretreatment alone, lane 5). 
3.4. Lack of direct effects of H7 and H8 on p opioid receptor 
Compounds H7 and H8 were recently shown to interfere 
with [3H]DAMG0 binding to rabbit brain homogenates [12], 
suggesting a possible direct interaction with the p opioid re- 
ceptor. We therefore determined the effects of 100 nM H7 and 
H8 on [3H]diprenorphine binding to intact HEK-p cells, and 
CAMP levels in the presence and absence of 10 pM morphine. 
In the buffer solution used in the CAMP accumulation assay 
(PBS buffer), neither H7 nor H8 affected [3H]diprenorphine 
tracer binding significantly. Further, H7 did not alter CAMP 
levels in the absence of morphine (106 + 9% of control), nor 
did it affect morphine (1 FM) inhibition of CAMP accumula- 
tion (-95% inhibition in this series of experiments). H8 
added alone enhanced CAMP levels in untreated cells 
(171? 7% of control), but it also did not block the inhibition 
by 10 pM morphine ( N 95% both in the presence and absence 
of HS). Therefore, H7 and H8 had no detectable acute effects 
on p receptor activity in HEK-p cells. 
4. Discussion 
The present study describes unique characteristics of the 
kinase activity responsible for basal p receptor phosphoryla- 
tion that differ from those of known receptor kinases [l]. 
First, basal p receptor phosphorylation appears to be 
mediated by a kinase with an unusual spectrum of inhibitors 
and ionic requirements. Second, basal p receptor kinase activ- 
ity is gradually regulated by an agonist over a time period of 
several hours, and it can be disrupted by preincubation with a 
suitable kinase inhibitor (H7). 
Basal n receptor phosphorylation was suppressed by addi- 
tion of the Ca2+ chelator EGTA, and the addition of Ca2+ 
restored the phosphorylating activity. Under these ionic con- 
ditions, including Ca2+ and Na+, any role of a known GRK 
in p receptor phosphorylation can be excluded, because 
GRKs are independent of Ca2+ and inhibited by Na+ 
[9,10]. Moreover, the Ca2+ requirement argues against a role 
for PKA and PKG which was further supported by insensi- 
tivity of basal p receptor phosphorylation to inhibitors of 
these kinases. Further, basal p receptor phosphorylation was 
not inhibited by Na+, which was therefore included with the 
incubations to suppress other intracellular kinases. Finally, 
the failure of a panel of selective kinase inhibitors, including 
chelerythrine, KN62 and W7, to strongly inhibit basal p re- 
ceptor phosphorylation argues against participation of PKC 
and Ca2+-calmodulin dependent kinase II. Future studies will 
focus on identifying the kinase(s) responsible for basal p phos- 
phorylation. 
Among the inhibitors tested in this study, H7 was shown to 
be the most effective inhibitor of basal p receptor phosphor- 
ylation, whereas H8 was only partially effective at 100 pM 
when added to the permeabilized cells (Fig. 2). However, 
when intact cells were pretreated with H7 and H8, only H7 
fully suppressed basal p receptor phosphorylation, and H8 
was inactive (Fig. 4B). The discrepancy between the partial 
inhibition with H8 in permeabilized cells (see above) and no 
effect in intact cells may be related to lower membrane per- 
meation by the more polar H8, compared to H7. Neverthe- 
less, H8 is generally considered a more potent inhibitor than 
H7 of PKC and PKA, and at 100 FM, it appears to penetrate 
sufficiently into the cell to inhibit PKA [6]. 
The distinct effects of H7 and H8 on basal p receptor phos- 
phorylation correlate with their different effects on the nalox- 
one induced CAMP overshoot in SH-SYSY cells [6]. Follow- 
ing morphine pretreatment, naloxone was shown to cause an 
increase in CAMP levels even though morphine had been com- 
pletely removed after the pretreatment period. We attributed 
this paradoxical effect of naloxone to an inverse agonist effect 
at a constitutively active p receptor state, p*, characteristic of 
the dependent state [6]. Similarly, inhibitor H7, but not H8 
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reversed morphine tolerance and naloxone induced withdra- 
wal jumping in mice [6,7]. Both H7 and H8 failed to interact 
directly with the p receptor under our experimental condi- 
tions. These results suggest a relationship between basal p 
receptor phosphorylation and morphine tolerance and de- 
pendence. However, several kinases are likely to mediate p 
receptor phosphorylation in vivo and to modulate narcotic 
effects. For example, in the absence of Na+, morphine stimu- 
lated some u receptor phosphorylation (Fig. 1, lane l), which 
could have been mediated by a GRK activity. Further, stimu- 
lation of PKC with phorbol esters leads to u receptor phos- 
phorylation [2]. Therefore, the in vivo phosphorylation pat- 
tern of the p opioid receptor is likely to depend on several 
kinases. 
Following inhibition of basal u receptor phosphorylation 
by H7, phosphorylation remained suppressed even though 
the inhibitor was removed from the incubation (Fig. 4). Con- 
versely, morphine enhanced the basal rate which persisted 
even after agonist removal (Fig. 4B). These results suggest a 
positive feed-back loop between receptor and kinase which is 
enhanced by a u agonist and disrupted by a kinase inhibitor. 
Studies on the time course indicated that the modulation of 
basal u receptor phosphorylation occurs over several hours 
(Fig. 5). 
Several mechanisms can account for long-term changes in 
receptor phosphorylation. Agonist activation of a G protein 
coupled receptor not only converts the receptor into a better 
substrate for GRK phosphorylation, but it also stimulates 
GRK activity directly [ 13,141. If phosphorylation, possibly 
involving more than one kinase, were to maintain the receptor 
in an active state, a positive feed-back loop would be estab- 
lished [15]. Another example of positive reinforcement of an 
initial signal is the translocation to the membrane and persist- 
ent activation of PKC as a result of receptor stimulation 
[ 16,171. Similarly, stimulation of Ca2+-calmodulin dependent 
kinase II results in auto-phosphorylation and enhanced acti- 
vation [18]. Such activation mechanisms outlast the initial 
signal and have been implicated in memory mechanisms. By 
analogy, continuous basal phosphorylation of the u opioid 
57 
receptor observed in this study could result from a positive 
feed-back loop as a novel regulatory mechanism, with possible 
relevance to narcotic tolerance and dependence. 
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